|
Name: Zopiclone
Type: Hypnotic
AKA: Lunesta
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Zopiclone, a non-benzodiazepine hypnotic, was developed in the 1980s. It is used to treat insomnia and is known for its effectiveness in improving sleep while having a lower risk of dependence compared to benzodiazepines.
|
|
V. Legal Information
Zopiclone is a non-benzodiazepine hypnotic used for treating insomnia. It is controlled in many countries due to its potential for dependence. In the United States, it is regulated similarly to other sleep aids, while international regulations aim to manage its use and prevent misuse. [Source: UNODC].
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Zopiclone is a non-benzodiazepine hypnotic used for treating insomnia. It causes sedation and impaired motor function. Short-term use is effective for managing sleep disorders, while long-term use can lead to dependence and tolerance. Overdose risks include severe sedation and respiratory depression. Safe use involves following prescribed dosages. Recent research highlights its efficacy in treating insomnia and potential risks associated with prolonged use.  |
|
VII. Psychological Effects
Zopiclone is a sedative used to treat insomnia, enhancing sleep quality and reducing anxiety. Long-term use may lead to dependence, cognitive impairments, and mood disturbances. Research highlights its impact on GABAergic systems and associated risks.
 |
|
VIII. Culture
Zopiclone is a sedative-hypnotic used for the treatment of insomnia, classifying it as a downer. Short-term use improves sleep quality, while long-term use can lead to dependence and tolerance. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 7.5 mg per day. Recent research highlights its efficacy in sleep management but warns of addiction risks. Physical effects include drowsiness, dizziness, and impaired coordination.
 |